Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Proteome Sciences ( (GB:PRM) ).
Proteome Sciences has completed an oversubscribed retail offer, expanding its size to raise £132,000 through the issue of 7,542,856 new shares at 1.75 pence each, bringing total gross proceeds from the broader fundraising to £972,000. The fresh capital will fund a series of strategic growth initiatives, including tripling the plexing rate of its TMT tags, launching a new range of DXT isotopic plex tags and concluding a licence for them, advancing its ‘Solvent Shift’ chemoproteomic workflows, and expanding both headcount and mass spectrometry capacity in San Diego, with the new shares expected to be admitted to trading on AIM on 29 January 2026 and increasing total voting rights to 350,724,912 shares.
The most recent analyst rating on (GB:PRM) stock is a Hold with a £2.00 price target. To see the full list of analyst forecasts on Proteome Sciences stock, see the GB:PRM Stock Forecast page.
Spark’s Take on GB:PRM Stock
According to Spark, TipRanks’ AI Analyst, GB:PRM is a Neutral.
The score is held down primarily by very weak financial performance (declining revenue, ongoing losses, negative cash flow, and negative equity). Technicals are also bearish with the stock below key moving averages, though oversold signals modestly offset the downside. Valuation is unfavorable due to a negative P/E and no dividend support.
To see Spark’s full report on GB:PRM stock, click here.
More about Proteome Sciences
Proteome Sciences plc is a UK-based life sciences company focused on proteomics, providing mass spectrometry-based services and proprietary tagging technologies such as Tandem Mass Tag (TMT) and DXT isotopic plex tags. The company targets pharmaceutical, biotech and research clients, with facilities including an expanding mass spectrometry operation in San Diego to support growing demand for advanced proteomic workflows.
Average Trading Volume: 340,702
Technical Sentiment Signal: Sell
Current Market Cap: £5.62M
See more insights into PRM stock on TipRanks’ Stock Analysis page.